About
Vaccine Adjuvant Products
Areas of Focus
Categories
Non-Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
224
By Phase
PHASE1: 2PHASE1/PHASE2: 1
By Status
NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06986239Lead Sponsor
Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant
PHASE1Not yet recruiting
80 participants
Started: Jul 1, 2025 · Completed: Jul 1, 2026
NCT06294262Lead Sponsor
Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Jan 29, 2024 · Completed: Mar 31, 2025
NCT05581407Lead Sponsor
Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin
PHASE1Completed
60 participants
Started: Oct 3, 2022 · Completed: Oct 23, 2023
Locations (1)
Headquarters
Oss, Netherlands
Map
Loading map...